Yusuke Furukawa
Overview
Explore the profile of Yusuke Furukawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osada N, Kikuchi J, Okada Y, Matsuoka S, Morishita K, Nakasone H, et al.
PLoS One
. 2024 Sep;
19(9):e0309533.
PMID: 39348376
Adult T-cell leukemia/lymphoma (ATL) develops from the infection of T cells with human T lymphotropic virus type 1 (HTLV-1). There are an estimated 5-20 million HTLV-1 carriers worldwide and the...
2.
Furukawa Y, Senoh H, Hirai S, Misumi K, Kasai T
J Toxicol Sci
. 2024 Sep;
49(9):385-398.
PMID: 39231683
We conducted a two-year inhalation study of butyraldehyde using F344/DuCrlCrlj rats. The rats were exposed to 0, 300, 1,000 and 3,000 ppm (v/v) for 6 hr/day, 5 days/ week for...
3.
Kikuchi J, Hori M, Osada N, Matsuoka S, Suzuki A, Kakugawa S, et al.
Haematologica
. 2024 Jun;
109(10):3414-3418.
PMID: 38867588
No abstract available.
4.
Iriuchishima H, Saito A, Mihara M, Terasaki Y, Matsumoto A, Isoda A, et al.
Int J Hematol
. 2024 Mar;
120(1):71-79.
PMID: 38551778
Background: Gain and amplification of 1q21 (1q21+) are adverse chromosomal aberrations of multiple myeloma (MM) that lead to refractoriness to a variety of therapies. While it is known that daratumumab,...
5.
Saito H, Furukawa Y, Sasaki T, Kitajima S, Kanno J, Tanemura K
Front Neurosci
. 2023 Sep;
17:1239808.
PMID: 37662107
Introduction: Acetamiprid (ACE) and imidacloprid (IMI), the neonicotinoid chemicals, are widely used as pesticides because of their rapid insecticidal activity. Although these neonicotinoids exert very low toxicity in mammals, the...
6.
Osada N, Kikuchi J, Iha H, Yasui H, Ikeda S, Takahashi N, et al.
Clin Transl Med
. 2023 Aug;
13(8):e1364.
PMID: 37581569
Background: The immunomodulatory drug lenalidomide, which is now widely used for the treatment of multiple myeloma (MM), exerts pharmacological action through the ubiquitin-dependent degradation of IKZF1 and subsequent down-regulation of...
7.
Furukawa Y, Hirai S, Kasai T, Senoh H, Takanobu K, Sasaki T, et al.
J Toxicol Sci
. 2023 Apr;
48(5):227-241.
PMID: 37121738
We conducted a two-year inhalation study of butyl methacrylate using F344/DuCrlCrlj rats and B6D2F/Crl mice. Rats were exposed to 0, 30, 125 and 500 ppm (v/v) and mice were exposed...
8.
Sasaki T, Saito H, Furukawa Y, Tominaga T, Kitajima S, Kanno J, et al.
J Toxicol Sci
. 2023 Apr;
48(4):211-219.
PMID: 37005279
Products used in daily life contain multiple chemicals capable of inducing endocrine disruption in animals, including humans. One such typical substance is bisphenol A (BPA). BPA has been widely used...
9.
Saito H, Tanemura K, Furukawa Y, Sasaki T, Kanno J, Kitajima S
J Toxicol Sci
. 2023 Apr;
48(4):203-210.
PMID: 37005278
Acetamiprid (ACE), a neonicotinoid chemical, is widely used as a pesticide due to its rapid insecticidal activity. Although neonicotinoids exert very low toxicity in mammals, the effects of early exposure...
10.
Yamano S, Takeda T, Goto Y, Hirai S, Furukawa Y, Kikuchi Y, et al.
Respir Res
. 2023 Feb;
24(1):47.
PMID: 36782232
Background: Recently in Japan, six workers at a chemical plant that manufactures resins developed interstitial lung diseases after being involved in loading and packing cross-linked water-soluble acrylic acid polymers (CWAAPs)....